Triazole Fungicides Can Induce Cross-Resistance to Medical Triazoles in Aspergillus fumigatus
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Triazole Fungicides Can Induce Cross-Resistance to Medical Triazoles in Aspergillus fumigatus
Authors
Keywords
-
Journal
PLoS One
Volume 7, Issue 3, Pages e31801
Publisher
Public Library of Science (PLoS)
Online
2012-03-03
DOI
10.1371/journal.pone.0031801
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Failure of Posaconazole Therapy in a Renal Transplant Patient with Invasive Aspergillosis Due to Aspergillus fumigatus with Attenuated Susceptibility to Posaconazole
- (2011) Saskia Kuipers et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- An Improved Model of the Aspergillus fumigatus CYP51A Protein
- (2011) M. G. Fraczek et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Azole Resistance in Aspergillus fumigatus Isolates from the ARTEMIS Global Surveillance Study Is Primarily Due to the TR/L98H Mutation in thecyp51AGene
- (2011) Shawn R. Lockhart et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- High-frequency Triazole Resistance Found In Nonculturable Aspergillus fumigatus from Lungs of Patients with Chronic Fungal Disease
- (2011) David W. Denning et al. CLINICAL INFECTIOUS DISEASES
- Comment on: Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies
- (2011) P. E. Verweij et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Impact of cyp51A Mutations on the Pharmacokinetic and Pharmacodynamic Properties of Voriconazole in a Murine Model of Disseminated Aspergillosis
- (2010) E. Mavridou et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Environmental Study of Azole-Resistant Aspergillus fumigatus and Other Aspergilli in Austria, Denmark, and Spain
- (2010) K. L. Mortensen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies
- (2010) A. Alanio et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Structural Basis of Human CYP51 Inhibition by Antifungal Azoles
- (2010) Natallia Strushkevich et al. JOURNAL OF MOLECULAR BIOLOGY
- Possible Environmental Origin of Resistance of Aspergillus fumigatus to Medical Triazoles
- (2009) E. Snelders et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Azole‐Resistant Central Nervous System Aspergillosis
- (2009) Jan W. M. van der Linden et al. CLINICAL INFECTIOUS DISEASES
- Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?
- (2009) Paul E Verweij et al. LANCET INFECTIOUS DISEASES
- Farm Fungicides Linked to Resistance in a Human Pathogen
- (2009) M. Enserink SCIENCE
- Multiple-azole-resistantAspergillus fumigatusosteomyelitis in a patient with chronic granulomatous disease successfully treated with long-term oral posaconazole and surgery
- (2008) Caspar J. Hodiamont et al. MEDICAL MYCOLOGY
- Evolution of the CYP51 gene in Mycosphaerella graminicola: evidence for intragenic recombination and selective replacement
- (2008) P. C. BRUNNER et al. MOLECULAR PLANT PATHOLOGY
- Emergence of Azole Resistance in Aspergillus fumigatus and Spread of a Single Resistance Mechanism
- (2008) Eveline Snelders et al. PLOS MEDICINE
- Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
- (2007) A. Pascual et al. CLINICAL INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now